169 followers
RT @FrontOncology: New research: Assessing Measurable Residual Disease in Chronic Myeloid Leukemia. BCR-ABL1 IS in the Avant-Garde of Molec…
RT @FrontOncology: New research: Assessing Measurable Residual Disease in Chronic Myeloid Leukemia. BCR-ABL1 IS in the Avant-Garde of Molec…
慢性骨髄性白血病における測定可能な残存疾患の評価。BCR-ABL1 は分子血液学の前衛にあります
New research: Assessing Measurable Residual Disease in Chronic Myeloid Leukemia. BCR-ABL1 IS in the Avant-Garde of Molecular Hematology: Chronic myelogenous leukemia (CML) is a malignancy of the myeloid cell lineage characterized by a recurrent… https://t.